Position in PFE
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$27,971,496
-$5,004,223 QoQ
Shares Held
1,161,607
-1.1% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#236
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$137,256
PutShares
5,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $381,609,244 across 14 Drug Manufacturers - General names. PFE ranks #6 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
365,648 | $92,863,622 | |
| 2 | LLY |
ELI LILLY & Co
|
61,241 | $73,454,298 | |
| 3 | ABBV |
AbbVie Inc.
|
195,761 | $49,261,298 | |
| 4 | MRK |
Merck & Co., Inc.
|
363,066 | $46,653,981 | |
| 5 | AMGN |
Amgen Inc
|
108,053 | $39,128,152 | |
| 6 | PFE |
Pfizer Inc
This page
|
1,161,607 | $27,971,496 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
232,697 | $13,408,001 | |
| 8 | NVS |
Novartis AG
|
84,234 | $13,201,152 |
All Filings in PFE
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $137,256 | 5,700 | Put | Sole | 2026-08-18 | |
| 2026-06-30 | $27,971,496 | 1,161,607 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $3,546,504 | 126,300 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $32,975,719 | 1,174,349 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $141,930 | 5,700 | Put | Sole | 2026-02-18 | |
| 2025-12-31 | $23,917,769 | 960,553 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $24,262,769 | 952,228 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $621,712 | 24,400 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $22,043,443 | 909,383 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $38,435,864 | 1,516,806 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $25,503,129 | 961,294 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $44,324,243 | 1,531,591 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,596 | 200 | Call | Sole | 2024-08-12 | |
| 2024-06-30 | $42,475,011 | 1,518,049 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $39,280,014 | 1,415,496 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $29,280,811 | 1,017,048 | Shares | Sole | 2024-02-08 | |
| 2023-12-31 | $2,879 | 100 | Call | Sole | 2024-02-08 | |
| 2023-09-30 | $3,317 | 100 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $44,800,363 | 1,350,629 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,854,356 | 486,760 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,144,869 | 469,237 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,901,820 | 466,468 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,233,832 | 439,530 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $22,067,996 | 420,904 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $27,917,024 | 539,251 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $15,855,928 | 268,517 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,733,300 | 272,804 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,314,853 | 186,794 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $3,274,576 | 90,383 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $3,438,495 | 93,412 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,774,553 | 75,601 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,629,605 | 80,416 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,192,164 | 67,162 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||